Brief: Genor Biopharma Holdings Posts H1 Net Income Attributable RMB -125.7 Million
28/08/2024 15:52
Aug 28 (Reuters) - Genor Biopharma Holdings H1 revenue RMB 14.5 million. * H1 net income attributable RMB -125.7 million
Recent news on Edding Genor group
See all newsBrief: JHBP CY Says Chairman And CEO Ni Xin To Buy Shares Up To USD 1 Million From Aug 31, 2026
Brief: Edding Genor Group Expects Revenue Of RMB850 MLN-RMB900 MLN For HY
Brief: Jhbp Cy Disposal Of Equity Interest In Candid Therapeutics
Edding Genor climbs on approval of clinical trial of cancer drug in China
Brief: JHBP CY's Phase Ib/Ii Clinical Trial Of Gb268 Obtains IND Approval By NMPA